entertainment -WSS

entertainment

author：leisure time 2025-10-01 22:57:35 - browse：657

Medical illustration of Streptococcus pneumoniae bacteria — A medical illustration of drug-resistant, Streptococcus pneumoniae bacteria. Antibiotic Resistance Coordination and Strategy Unit/CDC

Micronoma, a San Diego-based biotech startup, was founded on the idea that signatures from microbes that colonize tumors could lead to a blood test to detect cancer. The hypothesis was based on a high-profile Nature paper, published in 2020, that suggested these microbes are consistently found in tumors, and that they create such specific signatures they could be used to identify cancer types with nearly 100% accuracy.

But late Monday night, a team of researchers published a manuscript on the preprint site bioRxiv.com showing what they believe to be two “fatal errors” in the Nature paper’s analyses, invalidating not only the paper’s findings but possibly the scientific foundation for Micronoma, which has raised an estimated $17.5 million in funding from investors including SymBiosis Capital Management and the Seerave Foundation.

One allegation is that the Nature paper’s authors didn’t adequately filter out human DNA from their database of tumor samples, leading them to incorrectly classify millions of human sequences as bacterial. The other is that a separate error led the team’s algorithm to find false associations between specific microbial signatures and cancer types.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： The problem with charging patients to message their doctors

focus

WSS

What it’s like to watch children die of measles

Norman Reedus' Daryl Dixon

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Resistance to cancer drugs: A new genetic explanation

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Change Healthcare cyberattack prompts Medicare loan program

explore

entertainment

hotspot

Medical records are filled with copy

Former medical device CEO who sold dummy, plastic parts convicted of fraud

In age of alternative facts, a scholarly course on calling out crap

Trump got a 'target letter.' What is one and what does it mean?

BioMarin wins approval for gene therapy to treat hemophilia A

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

State Dept. review finds Biden bears some blame for Afghanistan failures

Change Healthcare cyberattack prompts Medicare loan program

In age of alternative facts, a scholarly course on calling out crap

Medical experts are missing from AI regulatory conversations

Wikipedia

The problem with charging patients to message their doctors

States increasingly look to regulate hospital facility fees

How dance can help health care workers heal from trauma

UnitedHealth quietly bought dozens of outpatient centers

IVF, abortion rights issues kick off Biden’s State of the Union

TikTok cracks down on users posting about weight loss drugs

knowledge

focus

explore

leisure time